These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 34470691)
1. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic. Chouhan M; Solanki B; Shakrawal N J Laryngol Otol; 2021 Nov; 135(11):981-986. PubMed ID: 34470691 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y; Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034 [TBL] [Abstract][Full Text] [Related]
3. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988 [TBL] [Abstract][Full Text] [Related]
4. Mucor in a Viral Land: A Tale of Two Pathogens. Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566 [TBL] [Abstract][Full Text] [Related]
5. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848 [TBL] [Abstract][Full Text] [Related]
6. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895 [TBL] [Abstract][Full Text] [Related]
7. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center. Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975 [No Abstract] [Full Text] [Related]
8. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
9. Rise of the phoenix: Mucormycosis in COVID-19 times. Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742 [TBL] [Abstract][Full Text] [Related]
10. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620 [TBL] [Abstract][Full Text] [Related]
12. Targeted orbital intervention in the management of sino-orbital mucormycosis cases. Meel R; Bajaj MS; Pushker N; Agrawal S; Tyagi P; Thakkar A; Sharma S; Pachaury SS; Wig N Indian J Ophthalmol; 2024 Oct; 72(10):1488-1494. PubMed ID: 39331440 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum. Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790 [TBL] [Abstract][Full Text] [Related]
15. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control. Mitra S; Janweja M; Sengupta A Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754 [TBL] [Abstract][Full Text] [Related]
16. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124 [TBL] [Abstract][Full Text] [Related]
17. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study. Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399 [TBL] [Abstract][Full Text] [Related]
18. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911 [TBL] [Abstract][Full Text] [Related]
19. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India. Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004 [TBL] [Abstract][Full Text] [Related]
20. Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study. Gandhi A; Narula A; Chandra S; Agarwal D; Mehta A; Nayak S; Arora S; Capoor MR Int Ophthalmol; 2023 May; 43(5):1571-1580. PubMed ID: 36273362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]